The deal was first announced in September. Intracept will be added to Boston Scientific’s chronic pain portfolio that includes spinal cord stimulation, radiofrequency ablation and an interspinous spacer procedure. Intracept recently earned national coverage from Anthem Blue Cross Blue Shield and Humana
The transaction includes an upfromt cash payment of $850 million and contingent payments based on sales over three years.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
